• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov6
Aquestive Therapeutic released FY2025 Q3 earnings on November 5 After-Market EST, actual revenue USD 12.81 M (forecast USD 12.94 M), actual EPS USD -0.14 (forecast USD -0.1325)
00:00
Aquestive Therapeutics released FY2025 9-month earnings on November 5 After-Market EST, actual revenue USD 31.53 M, actual EPS USD -0.5161
00:00
Oct29
Aquestive Therapeutic to Release FY2025 Q3 Earnings on November 5 After-Market (EST), Forecast Revenue USD 12.94 M, EPS USD -0.1325
00:49
Oct8
Aquestive Therapeutics Inc. Obtains New Patents for Anaphylm™
11:00
Sep4
Aquestive Therapeutics Inc Announces FDA Will Not Require an Advisory Committee Meeting to Discuss New Drug Application
11:01
Aug11
Aquestive Therapeutic released FY2025 Semi-Annual earnings on August 11 After-Market EST, actual revenue USD 18.72 M, actual EPS USD -0.3744
23:00

Schedules & Filings

Schedules
Filings
Nov5
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 12.81 M, Net Income -15.45 M, EPS -0.1396

Aug11
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 10 M, Net Income -13.55 M, EPS -0.1363

May12
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 8.72 M, Net Income -22.93 M, EPS -0.2401

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
FJET
8.500
+136.77%
+4.910
AFJK
52.230
+100.81%
+26.220
DJTU
5.160
+83.63%
+2.350
ATHA
6.720
+62.52%
+2.585
SOC
8.250
+56.25%
+2.970
ZNB
1.020
+55.73%
+0.365
VIVK
0.0751
+47.25%
+0.024
SGD
0.2518
+42.26%
+0.075
DJT
14.860
+41.93%
+4.390
VSME
0.1035
+38.37%
+0.029
View More